Intracranial Angioplasty and Stenting before and after SAMMPRIS: From simple to complex strategy - the Chinese experience
Intracranial atherosclerotic disease (ICAD) accounts for 33% to 50% of all ischemic strokes in the Asian population [1] and represents an important public health issue in China. The results of the SAMMPRIS trial alarmed most experienced interventionalists in China for two reasons. Firstly, the high...
Main Author: | Zhongrong eMiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-07-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00129/full |
Similar Items
-
Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
by: Haowen Xu, et al.
Published: (2020-08-01) -
Reviving Intracranial Angioplasty and StentingSAMMPRIS and Beyond
by: Muhammad U. Farooq, et al.
Published: (2014-06-01) -
Angioplasty, Stenting and Other Potential Treatments of Atherosclerotic Stenosis of the Intracranial Arteries: Past, Present and Future
by: Ashley Wabnitz, et al.
Published: (2017-09-01) -
SUCCESSFUL THROMBOEMBOLECTOMY THROUGH THE RIGHT INTERNAL CAROTID ARTERY LUMEN WITH STENT-RETRIEVER APPLICATION AND FURTHER BALLOON ANGIOPLASTY
by: A. I. Beliy, et al.
Published: (2019-02-01) -
Drug-Coated Balloons for the Treatment of Symptomatic Intracranial High-Grade Stenosis: A Review of the Current Rationale
by: Philipp Gruber, et al.
Published: (2021-07-01)